Your browser doesn't support javascript.
loading
Cardiorespiratory fitness decreases the odds for subclinical carotid plaques in apolipoprotein e4 homozygotes.
Perez-Lasierra, Jose Luis; Casajús, José A; Gonzalez-Agüero, Alejandro; Arbones-Mainar, José Miguel; Casasnovas, José A; Laclaustra, Martin; Moreno-Franco, Belén.
Afiliação
  • Perez-Lasierra JL; Department of Physiatry and Nursing, Universidad de Zaragoza, Zaragoza, Spain.
  • Casajús JA; GENUD (Growth, Exercise, Nutrition and Development) Research Group, Zaragoza, Spain.
  • Gonzalez-Agüero A; EXERNET Red de Investigación en Ejercicio Físico Y Salud, Zaragoza, Spain.
  • Arbones-Mainar JM; Department of Physiatry and Nursing, Universidad de Zaragoza, Zaragoza, Spain.
  • Casasnovas JA; GENUD (Growth, Exercise, Nutrition and Development) Research Group, Zaragoza, Spain.
  • Laclaustra M; EXERNET Red de Investigación en Ejercicio Físico Y Salud, Zaragoza, Spain.
  • Moreno-Franco B; Centro de Investigación Biomédica en Red de Fisiopatología de La Obesidad Y Nutrición (CIBEROBN), Madrid, Spain.
Sci Rep ; 12(1): 19196, 2022 11 10.
Article em En | MEDLINE | ID: mdl-36357490
ABSTRACT
Some studies suggest that being an apolipoprotein e4 (APOE e4) carrier increases the risk of atherosclerosis, and others suggest that cardiorespiratory fitness (CRF) could play a key role in atherosclerotic prevention. Our aim was to analyze the association of APOE e4 with carotid atherosclerosis and the association of CRF with atherosclerosis in APOE e4 carriers. A cross-sectional analysis based on a subsample of 90 participants in the Aragon Workers' Health Study was carried out. Ultrasonography was used to assess the presence of plaques in carotid territory; the submaximal Chester Step Test was used to assess CRF; and behavioral, demographic, anthropometric, and clinical data were obtained by trained personnel during annual medical examinations. APOE e4e4 participants were categorized into Low-CRF (VO2max < 35 mL/kg/min) and High-CRF (VO2max ≥ 35 mL/kg/min) groups. After adjusting for several confounders, compared with APOE e3e3, those participants genotyped as APOE e3e4 and APOE e4e4 showed an OR = 1.60 (95% CI 0.45, 5.71) and OR = 4.29 (95% CI 1.16, 15.91), respectively, for carotid atherosclerosis. Compared to Low-CRF APOE e4e4 carriers, the odds of carotid plaque detection were 0.09 (95% CI 0.008, 0.98) times lower among High-CRF APOE e4e4 carriers. The APOE e4e4 genotype was associated with increased carotid atherosclerosis. However, CRF is a modifiable factor that may be targeted by APOE e4e4 to decrease the elevation of atherosclerotic risk due to this genetic condition.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças das Artérias Carótidas / Aterosclerose / Placa Aterosclerótica / Aptidão Cardiorrespiratória Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doenças das Artérias Carótidas / Aterosclerose / Placa Aterosclerótica / Aptidão Cardiorrespiratória Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Sci Rep Ano de publicação: 2022 Tipo de documento: Article